GEMA |
|
|
|
|
Proportion of adherence |
|
|
|
|
Previous day |
|
97.2 (15.8) *
|
100 |
0-100 |
Adequate doses (≥ 80%) |
123 (96.8) |
|
|
|
Inadequate doses (<80%) |
4 (3.2) |
|
|
|
Past week |
|
96.6 (11) |
100 |
0-100 |
Adequate doses (≥ 80%) |
120 (94.5) |
|
|
|
Inadequate doses (<80%) |
7 (5.5) |
|
|
|
Past month |
|
96.3 (10.8) *
|
100 |
0-100 |
Adequate doses (≥ 80%) |
121 (95.2) |
|
|
|
Inadequate doses (<80%) |
6 (4.7) |
|
|
|
Global evaluation of adherencea |
|
|
|
|
Previous day |
|
|
|
|
Adherent (Group I) |
107 (84.2) ***
|
|
|
|
Non-adherent (Groups II, III and IV) |
20(15.8) |
|
|
|
Past week |
|
|
|
|
Adherent (Group I) |
92 (72.4) **
|
|
|
|
Non-adherent (Group II, III and IV) |
35 (27.6) |
|
|
|
Past month
|
|
|
|
|
Adherent (Group I) |
83(65.3) ***
|
|
|
|
Non-adherent (Group II, III and IV) |
44(34.7) |
|
|
|
Brazilian version of MAT |
|
5.6 (0.4) |
5.7 |
4.1-6.0 |
Adherent |
120 (94.5) |
|
|
|
Non-adherent |
7 (5.5) |
|
|
|
Brazilian version of MMAS-8 |
|
7.2 (1) |
7.5 |
3.5-8.0 |
Adherent |
58 (45.7) |
|
|
|
Non-adherent |
69 (54.3) |
|
|
|